15 Stocks Moving In Thursday's Pre-Market Session

Gainers

• Aerie Pharmaceuticals Inc AERI shares rose 63 percent to $34.44 in pre-market trading on news about its Phase 3 study of Roclatan having met its primary efficacy endpoint.
• AcelRx Pharmaceuticals Inc ACRX shares rose 12.8 percent to $3.70 in pre-market trading after the company disclosed that its investigational product candidate ARX-04 provided solid tolerance level in an open-label Phase three trial for post operative acute pain treatment.
• Apogee Enterprises Inc APOG rose 8 percent to $49.80 in the pre-market trading after the company reported better-than-expected Q2 results and boosted its fiscal 2017 outlook.
• Acacia Research Corp ACTG rose 5.8 percent to $6.42 in pre-market trading. Acacia Research spokesperson confirmed to Benzinga that they 'won a patent trial against Apple'.
• bluebird bio Inc BLUE shares rose 5 percent to $66.00 in pre-market trading. Goldman Sachs added bluebird bio to Conviction Buy list.
• Lakeland Industries, Inc. LAKE rose 4.8 percent to $9.83 in pre-market trading. Lakeland Industries reported Q2 earnings of $0.20 per share on revenue of $22.26 million.
• CoLucid Pharmaceuticals Inc CLCD rose 4.7 percent to $24.37 in the pre-market trading session after gaining 4.72 percent on Wednesday.
• Achillion Pharmaceuticals, Inc. ACHN shares rose 2.6 percent to $7.90 in pre-market trading after gaining 0.92 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Aralez Pharmaceuticals Inc ARLZ shares fell 12.1 percent to $4.80 in pre-market trading after dropping 10.93 percent on Wednesday.
• Star Bulk Carriers Corp. SBLK shares fell 10.1 percent to $4.20 in pre-market trading. Star Bulk Carriers reported a Q2 loss of $0.75 per share on revenue of $52.6 million and announced a $51.5 million offering of common stock.
• Sequans Communications SA ADR SQNS fell 5.3 percent to $1.80 in pre-market trading after reporting an offering of ADSs.
• Platform Specialty Products Corp PAH shares fell 5.1 percent to $8.50 in pre-market trading after announcing a $350 million stock offering.
• Sarepta Therapeutics Inc SRPT shares fell 3.3 percent to $31.40 in pre-market trading amid negative Jefferies note. Jefferies reiterated Underperform rating with $7 price target on Sarepta.
• MCBC Holdings Inc MCFT shares fell 3.3 percent to $10.38 in pre-market trading after the company reported the pricing of follow-on offering.
• Lexicon Pharmaceuticals, Inc. LXRX fell 2.1 percent to $18.45 in pre-market trading after the company reported the extension of PDUFA date for telotristat etiprate for the treatment of carinoid syndrome.